Welcome to The Visible Embryo

Home- - -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- News Alerts -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo in 1993 as a first generation internet teaching tool consolidating human embryology teaching for first year medical students.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human.

The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform
The World Health Organization (WHO) has created a new Web site to help researchers, doctors and patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Archive
Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFemale Reproductive SystemFertilizationThe Appearance of SomitesFirst TrimesterSecond TrimesterThird TrimesterFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterDevelopmental Timeline
Click weeks 0 - 40 and follow fetal growth
Search artcles published since 2007

December 25, 2012--------News Archive Return to: News Alerts

Head Tail

This image of a developing Drosophila embryo displays the forming musculature
labeled with green fluorescent protein; while (shown in red) neuronal cells are stained with an antibody against the neuron-specific Elav protein.

Researchers found no evidence that poised Pol II is recruited in tissue-specific manner. Instead recruitment appears to be developmental stage-specific rendering genes permissive for future expression..

Image: Courtesy of Bjoern Gaertner, Stowers Institute for Medical Research

WHO Child Growth Charts


Cellular Patterns of Development

New research finds that key mechanism in development involves 'paused' RNA polymerase

For a tiny embryo to grow into an entire fruit fly, mouse or human, the correct genes in each cell must turn on and off in precisely the right sequence. This intricate molecular dance produces the many parts of the whole creature, from muscles and skin to nerves and blood.

So what are the underlying principles of how those genes are controlled and regulated?

At the most basic level, scientists know genes are turned on
when an enzyme called RNA polymerase binds to the DNA at the beginning of a gene.

The RNA polymerase copies the DNA of the gene into
a complementary strand of messenger RNA, which then
instructs the cell to make a protein coded for by the gene.

But several years ago, Julia Zeitlinger, Ph.D., now an
assistant investigator at the Stowers Institute, made a
surprising discovery.

RNA polymerase doesn't just attach to DNA and start
copying. Instead, it binds and then pauses, waiting for
another signal before it goes to work.

In many cases, therefore, the key regulatory step isn't
getting the polymerase to the gene, it is re-starting
the paused enzyme.

"The dogma was that the recruitment of polymerase is the rate-limiting step," Zeitlinger explains. "Suddenly it was clear that this isn't always true." For many genes, the presence of paused polymerase indicates whether a gene is poised and ready for transcription.

Now, new research by Zeitlinger's lab, described in the December 27, 2012, issue of Cell Reports, has revealed far more about the role of paused RNA polymerase in embryonic development—and turned up another surprise.

The Stowers scientists looked for genes with poised polymerase at five separate developmental stages in fruit fly muscle cells, from the very early embryo (the mesoderm) to fully differentiated muscle cells. They also compared the development of muscle cells to that of nerve cells.

Such work hadn't been done before because it requires examining a large number of cells and developing new software programs and methods of analysis. Graduate student Bjoern Gaertner did most of the lab work, while bioinformatician Jeff Johnston performed most of the analysis.

The question is whether genes can switch between having a poised polymerase and having no polymerase at all. The general expectation was that such differences would be found between different cell types. After all, sets of specific genes have to be activated to make muscle or nerve, and thus it might be wise to turn the wrong genes off when the cell type is fully developed.

However, the team found that the pattern of genes with poised polymerase varied depending on the stage of development. "It was surprising that the poised state was regulated over time, rather than by tissue type," says Zeitlinger.

So how then can a single cell give rise to all cell types without turning on the wrong genes? The answer, the new research suggests, is that there are other regulatory mechanisms at work that keep the poised polymerase in check. The team found that this can be accomplished by a family of proteins called the Polycomb group, which has previously been implicated in repressing the poised polymerase.

The Stowers team found that the action of these proteins
varies by tissue type and thus can prevent the wrong
poised genes from being turned on.

Together, these two mechanisms explain how genes
during the development of both muscle and nerves
can be first poised to be expressed at the right time
by paused polymerase, but then only actually
activated in the right tissue type.

That's not the whole story, though. Zeitlinger's team
also found that some genes don't actually need paused
polymerase at all to be turned on.

These genes have a distinctive DNA sequence
TATA—in their promoter regions.

"What we found is that these promoters work in a fundamentally different way," Zeitlinger says. "It's very exciting."

Given the vast number of data and the complexity of the analysis, "this research took us a long time," says Zeitlinger. There are also many additional questions to be answered, such as what are the biochemical signals that bring the poised polymerase to genes over time.

But the work is bringing unprecedented clarity and detail to the complicated story of gene regulation. And because the researchers were able to show that the same mechanisms are at work in human cells too, the findings could eventually lead to a better understanding of disease.

Zeitlinger: "The bigger vision is being able to understand the biochemical changes in development and map how development actually works. And if we understand the cell better, we may be able to better predict what is going to happen in a diseased or cancer cell."

Researchers who also contributed to the work include Kai Chen, Nina Wallaschek, Ariel Paulson, Alexander S. Garruss, Karin Gaudenz, Bony De Kumar and Robb Krumlauf, all at the Stowers Institute for Medical Research.

The work was funded in part by the Stowers Institute for Medical Research and NIH New Innovator Award 1DP2 OD004561-01.

About the Stowers Institute for Medical Research

The Stowers Institute for Medical Research is a non-profit, basic biomedical research organization dedicated to improving human health by studying the fundamental processes of life. Jim Stowers, founder of American Century Investments, and his wife, Virginia, opened the Institute in 2000. Since then, the Institute has spent over 900 million dollars in pursuit of its mission.

Currently, the Institute is home to nearly 550 researchers and support personnel; over 20 independent research programs; and more than a dozen technology-development and core facilities.

Original article: http://www.stowers.org/media/news/dec-20-2012